Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01208987 · ClinicalTrials.gov registry record · NA

Improving Laboratory Follow-up by Delivering an Enhanced Medication List to Outpatient Physician Practices

A NA study, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
5,256
Enrollment target

NCT01208987 is a NA study that has completed, run by Indiana University. The registered enrollment target is 5,256 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01208987, a NA study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
5,256 participants
Enrollment target

Study Summary

The investigators plan to develop a process to create an Enhanced Medication List. The INPC (Indiana Network for Patient Care) already obtains histories of medications dispensed by pharmacies from several sources: pharmacy benefit managers, RxHub, insurance companies, Medicaid, SureScripts, Wishard Health Services. The investigators will collect all the medication data available through the INPC for an individual patient. The investigators will enhance this medication list by including medication categories, improving the structure and appearance, displaying results of relevant laboratory tests, and adding decision support reminders. The investigators will test the value of such an "Enhanced Medication List" by providing it to outpatient physician practices (through the DOCS4DOCS clinical messaging service, or as a fax), preferably on the day that the patient has an office visit with the physician. The investigators will determine whether this intervention improves patient care: whether there are higher rates of recommended laboratory follow-up monitoring as a result; whether there are lower rates of harmful drug-drug interactions. The investigators will also seek the opinions of physicians regarding the benefit of this intervention.

Interventions

  • OTHER Medication History was printed

Trial Details

FieldValue
Enrollment Target 5,256 participants
Start Date 2007-09-28
Est. Completion 2011-10-01
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT01208987

The ClinicalTrials.gov registry entry for NCT01208987 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,256 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Medication History was printed is the first listed.

NCT01208987 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01208987 about?

NCT01208987 is a clinical study titled "Improving Laboratory Follow-up by Delivering an Enhanced Medication List to Outpatient Physician Practices". The investigators plan to develop a process to create an Enhanced Medication List. The INPC (Indiana Network for Patient Care) already obtains histories of medications dispensed by pharmacies from several sources: pharmacy benefit managers, RxHub, insurance companies, Medicaid, SureScripts, Wishard ...

What is the current status of trial NCT01208987?

This trial is currently completed. It is a NA study. The enrollment target is 5,256 participants. The study started on 2007-09-28. Estimated completion is 2011-10-01.

What interventions are being tested in trial NCT01208987?

The interventions under investigation include: Medication History was printed (OTHER).

Who is sponsoring clinical trial NCT01208987?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.